TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2026
Back to search
Official data from USPTO
M MENARINI PILLS OF RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Quick snapshot
ST13
US500000079326473Class
5, 9, 16, 41, 42
Filing
79326473
Registration
7051061
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
08/04/2026
Trademark type
Combined
Nice classes
5, 9, 16, 41, 42
Filing date
04/19/2021
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
08/04/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
IT
Examiner
MCCAULEY, BRENDAN D
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an upper-case stylized letter "M" outlined in black on a square outlined in black, the interior of the letter is white, the two right triangles formed by the bottom of the "M" are the color red outlined in black, and the large isosceles triangle formed at the top of the letter "M" is black and is bisected from the bottom to top by the stylized name "MENARINI" in white. On the right side of the letter "M" are the stylized words "PILLS OF" in black with the stylized orange word "RESEARCH" underneath.
Holders and representatives
Holders
A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.
Representatives
Arthur J. DeBaugh Allman Spry Leggett Crumpler & Horn, P.A.
Technical classification
Nice Classes
Class 5Class 9Class 16Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antibiotics; anti-cancer preparations; pharmaceutical preparations for the treatment of inflammatory disorders; medicated preparations for skin treatment; pharmaceutical preparations for treating skin disorders
Class 9
Blank magnetic data carriers; recording discsblank compact discsblank audio discsblank computer discs; recording discsaudio discs and compact discs featuring information on research and development in the pharmaceutical and biotechnology fields; DVDs featuring information on research and development in the pharmaceutical and biotechnology fields; blank compact discs; digital recording mediapre-recorded video cassettesdigital video discsdigital versatile discsdownloadable audio and video recordingsDVDshigh definition digital discs featuring information on research and development in the pharmaceutical and biotechnology fields; downloadable computer software for editing cinematographic film and for creating videos; apparatus for editing cinematographic film; electronic downloadable publicationsnewsletters and magazines in the field of medicine; camcorders; photographic cameras; cinematographic films featuring information on medicine; musical sound recordings; musical video recordings; blank USB flash drives
Class 16
Paper; paper stationery; printed materialsbooksmagazinesprinted matter in the nature of printed bookletscataloguesprinted publications in the nature of newsletters and brochures and pamphlets in the fields of pharmaceutical drugsmedicine and art; stationery; writing stationery; cardboard boxes; conical paper bags; printed postcards; printed advertising posters; printed mounted posters; printed photographs; placards of paper; placards of cardboard; signboards of paper; printed calendars; printed almanacs; copyholders; paperweights; pencil holders; pens; writing or drawing books; printed diaries
Class 41
Education servicesarranging and conducting of seminarsconferences and conventions in the fields of pharmaceutical drugsartmedicine; organization of educationalentertainmentsportingcultural eventsevents in the fields of pharmaceutical drugsartmedicine for cultural or educational purposes; digital videoaudiomultimedia publishing services; organization of cultural activities in the fields of pharmaceutical drugsmedicineart; production of radio and television entertainment services; audio recording and video productionphotography; production of television programs
Class 42
Pharmaceutical research services; scientific research; genetic research; medical research; biological research; biotechnology research; laboratory research services relating to pharmaceuticals; research services relating to pharmaceuticals; scientific research services; biomedical research services; bacteriological research and analysis; stem cell research services; research and development of vaccines and medicines; research and development in the pharmaceutical and biotechnology fields
Publications
History of USPTO decisions and trademark events.
43 publications found
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/02/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2026
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
10/03/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
08/18/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
08/18/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/16/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2023
PUBO
PUBLISHED FOR OPPOSITION
02/28/2023
GPNX
NOTIFICATION PROCESSED BY IB
02/27/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/08/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/08/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/25/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
01/25/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/25/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
01/25/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/25/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/24/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/24/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/24/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/25/2022
GNFR
FINAL REFUSAL E-MAILED
07/25/2022
CNFR
FINAL REFUSAL WRITTEN
07/25/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/27/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/25/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/25/2022
ATRV
ATTORNEY REVIEW COMPLETED
05/02/2022
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
04/28/2022
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
03/20/2022
RFNT
REFUSAL PROCESSED BY IB
02/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/11/2022
RFRR
REFUSAL PROCESSED BY MPU
01/10/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/16/2021
CNRT
NON-FINAL ACTION WRITTEN
12/15/2021
MAFR
APPLICATION FILING RECEIPT MAILED
12/14/2021
DOCK
ASSIGNED TO EXAMINER
12/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/08/2021
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/25/2021
Continuous trademark protection
Get notified about every new filing that threatens M MENARINI PILLS OF RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.